Moderate mRNA levels were observed in dentate gyrus, cerebral cortex, medial thalamic nuclei, and brainstem, whereas negligible mRNA was detectable in the globus pallidus, islands of Calleja, substantia nigra, and ventral tegmental area. lmmunocytochemistry confirmed that the majority of PDEl Bl protein was localized to the caudate-putamen, nucleus accumbens, and olfactory tubercle.
Within the caudate-putamen, PDEl Bl immunoreactivity was ubiquitous, while PDE 1 A2 immunostaining was restricted to a minor subset of striatal neurons. Cyclic nucleotides, acting as "second messengers" or via direct effects, regulate a diverse array of neuronal functions, from ion channel conductance to gene expression. Hydrolysis of 3',5'-cyclic nucleotides to 5'-nucleoside monophosphates is the major mechanism for decreasing intracellular cyclic nucleotide levels. This reaction is catalyzed by cyclic nucleotide phosphodiesterase (PDE) enzymes that constitute a large superfamily (Beavo and Reifsynder, 1990) . One family of PDE isozymes, which is highly enriched in brain compared to other tissues, is regulated by calcium (Ca2+ ) through the Ca 2+-binding protein calmodulin (CaM). This apparent emphasis on Ca*+ modulation of cyclic nucleotide degradation suggests a close coupling of second messenger pathways in neural tissue. Although the CaM-dependent PDEs comprise only a small percentage (0.03%) of total cellular protein in mammalian brain (Kincaid, 1987a) , they are very efficient catalysts, exhibiting maximal turnover rates of 150-300 set-I. Based on in vitro studies, CaM-PDEs are by far the predominant physiological regulators of cyclic nucleotide catabolism in brain, accounting for > 90% of PDE hydrolytic activity at micromolar cyclic nucleotide concentrations (Kincaid et al., 1981) .
Biochemical and immunological studies have identified two major neuronal CaM-PDE isoforms that exhibit apparent subunit sizes of 63 and 61 kDa (Sharma et al., 1984) . The significance of such multiple Ca*+/CaM-regulated PDE isoforms in brain is not clear and it is not known if these isozymes are colocalized in neurons or how their expression and activity are regulated in vivo. Previous studies using an affinity-purified polyclonal antibody demonstrated that CaM-PDE is highly enriched in specific neuronal populations such as neocortical and hippocampal pyramidal cells, and cerebellar Purkinje cells (Kincaid et al., 1987b) ; immunoreactivity was present in the somatic cytoplasm and throughout the extensive dendritic arborizations of these major output neurons. Electron microscopic studies further demonstrated that CaM-PDE immunoreactivity was highly localized in the postsynaptic region of asymmetric synapses (Ludvig et al., 199 l) , suggesting that CaM-PDEs subserve an important function in the dendrites of neurons that integrate multiple inputs.
Recently, cDNAs encoding the PDE 1 B 1(63 kDa) and PDE IA2
(61 kDa) neuronal CaM-PDE isoforms were characterized (Bentley et al., 1992; Polli and Kincaid, 1992; Repaske et al., 1992; Sonnenburg et al., 1993) . These isozymes are products of two separate but homologous genes (Novack et al., 1991 ) that appear to have diverged long ago. The most striking difference between these two isoforms lies in the expression of their mRNAs in the brain. The mRNA encoding the PDElBl isoform is expressed at 4-30-fold higher levels in the striatum than in other brain regions (Polli and Kincaid, 1992) , whereas PDE I A2 mRNA appears to be more evenly distributed (Sonnenburg et al., 1993) .
Although the immunocytochemical distribution ofCaM-PDE in the adult and developing CNS has been carefully documented (Billingsley et al., 1990) (Polli and Kincaid, 1992) was amplified by PCR using primers containing BamHI restriction sites. The amplified DNA fragment was digested with BamHI, purified by polyacrylamide gel electrophoresis, and subcloned into BamHI-digested pVL1393 baculovirus expression vector. The PDElBl/pVLl393 construct was transfected into St9 cells using a BaculoGold transfection kit (Pharmingen, San Diego, CA). Recombinant PDElB 1 virus was plaquepurified and high-titer viral stocks were prepared. For protein production. St9 cells were grown at 27°C in spinner flasks using. St90011 fGIB-CO/Bethesda Research Labs) media containing (50 &ml) gentamicin. Cells (1 S-2.0 x 1 06/ml) were infected at multiplicity of infection (MOI) = 5 and incubated for 72 hr, and recombinant PDEl Bl protein was purified by calmodulin-Sepharose chromatography (Kincaid and Vaughan, 1988) .
Animal housing and care. Male C57/BL6 mice (4-6 weeks of age) were used in all experiments and were obtained from the National Cancer Institute-Frederick Cancer Research Facility. Mice were housed in groups of three to five, kept on a 12 hr: 12 hr light/dark cycle, and fed ad libitum with Ziegler (NIH open Formula, Autoclavable) that was not autoclaved. Prior to any surgical procedures, animals were anesthetized with sodium pentobarbital (50 mg/kg) by intraperitoneal injection. All animal procedures were reviewed and approved by the Institutional Animal Care and Use Committee.
Preparation ofantibodies against PDElBI. The peptide Glu-Glu-AlaPro-Ser-Ser-Pro-Ala-Glu-Asp-Glu-His-Asn. renresentina amino acids 5 17-529 of mouse brain PDEl Bl (Polli and Kmcaid, 1592) , was synthesized by Cambridge Research Biochemicals (Wilmington, DE). An anti-peptide antibody was raised by immunization of rabbits with peptide conjugated to keyhole limpet hemocyanin through a cysteine added to the peptide amino terminus. Immunization and antibody purification procedures were essentially as described (Rathna Giri et al., 1992) . Briefly, antisera were purified by affinity chromatography using peptide coupled to CH-Sepharose (substituent concentration of 0.5 mg peptide/ ml of gel). Antibodies were eluted with 25 mM sodium acetate buffer, pH 4.8, containing 6 M urea, 0.5 M NaCl, 2 mM EDTA, and 2 mM EGTA. Eluates were neutralized immediately with 2 M Tris-HCl, pH 9.0. and dialvzed against Tris-buffered saline (TBS: 50 mM Tris-HCl. pH'7.4, 150 &M Na?I) containing 40 % glycerol. To purify the antibody further, a second round of affinity chromatography was completed using recombinant PDElBl protein that had been coupled to CNBr-Sepharose (substituent concentration of 1 mg'ml). Antibody eluted from the peptide columns was pooled and NaCl added to a final concentration of 0.35 M. The pooled antibody (-10 mg of IgG) was rocked overnight with the PDE 1 B 1 CNBr-Sepharose at 4°C. The column (1 ml bed vol) was washed with 5 bed vol of 50 mM Tris-HCl pH 7.4, 350 mM NaCl. Antibody was eluted as described above and immediately dialyzed against TBS/40% glycerol.
Isolation ofbrain tissues. Tissue was isolated from six discrete brain regions (cerebral cortex with olfactory tubercle, hippocampus, striatum, cerebellum, olfactory bulb, and hindbrain) and homogenized in 3 vol of ice-cold 10 mM Tris-HCI, pH 7.2, 1 mM EDTA, 1 mM EGTA, 20 KM leupeptin, 15 PM antipain, 0.5 @M soybean trypsin inhibitor, 3 FM pepstatin A, and 575 FM phenylmethylsulfonyl fluoride. Homogenates were centrifuged at 100,000 x g for 30 min and cytosolic fractions (S3) isolated. The protein content offractions was determined by the method of Bradford (1976) .
Polyacrylamide gel electrophoresis and immunoblotting analysis. SDSpolyacrylamide gel electrophoresis was carried out using 9% acrylamide gels. After electrophoresis, gels were either stained with Coomassie brilliant blue R-250 or used for electrophoretic transfer of proteins to nitrocellulose (Towbin et al., 1979) . After blocking in a solution of 3% nonfat dry milk (Carnation) in dissolved TBS. blots were incubated with antibodies, washed and developed with bromochloroindolyl phosphate and nitro-blue tetrazolium as described (Polli et al., 199 I) .
In situ hybridization (ISH). The open reading frame (1605 base pairs) of mouse brain PDElBl (Polli and Kincaid, 1992) was amplified by PCR using oligonucleotide primers that contained either an EcoRI or BamHI restriction site on the 5' terminus. The amplified DNA fragment was digested, purified, and subcloned into the EcoRI/BaMHI sites of the pGEM3Z vector (Promega). In vitro transcription was completed in 40 mM Tris-HCl pH 7.6, 6 mM MgCl,, 2 mM dithiothreitol (DTT), 5 U of rRNasin, 400 PM each of ATP, GTP, and CTP, 25 PM ?S-UTP (800 Ci/mmol; Amersham), 1 pg of linearized plasmid (EcoRI for "antisense" riboprobe or BamHI for "sense" riboprobe), and 15 U of SP6 (antisense riboprobe) or T7 (sense riboprobe) RNA polymerase, and incubated at 37°C for 60 min. After transcription, the DNA template was digested with RNase-free DNase (Promega) for 30 min at 37°C and transcripts subjected to alkaline cleavage as described (Wilson and Higgins, 1989) . Following alkaline cleavage, transcripts were extracted with water-saturated phenol:chloroform (1: l), followed by an extraction with chloroform:isoamyl alcohol (49: I) and unincorporated nucleotides were removed using G-50 Sephadex spin columns (Boehringer Mannheim). All riboprobes had specific activities of > lo9 cpm/pg.
For ISH, brains were fresh frozen and sections (20 pm) were mounted on silanized slides (Oncor, Gaithersburg, MD) by gently warming the section to room temperature. Prior to hybridization, sections were pretreated as described (Young et al., 1986) . Briefly, sections were postfixed for 5 min in 4% paraformaldehyde dissolved in phosphate-buffered saline (PBS; pH 7.4) at room temperature, rinsed twice in PBS (5 min each), and acetylated in 0.1 M triethanolamine pH 8.0, 0.9 % NaCI, 0.25% acetic anhydride for 10 min. Following acetylation, sections were dehydrated through a series of graded alcohols (70%, SO%, 95%, and 100%) and chloroform, and then dried at 37°C. As a control, several slides were treated after the acetylation step with RNase A (50 pg/ml in 0.1 mM Tris pH 7.6, 0.2 M NaCl, and 1 mM EDTA) for 30 min at 37°C. After incubation in RNase A, 'these slides were incubated in 4% paraformaldehyde/PBS to inactivate the ribonuclease, rinsed twice in PBS, and dehydrated. The remaining. steps of the method were similar to those described by Wilson and H&ins (1989) . All slides were urehybridized for 2 hr at 42°C in 50% formamide, '0.75 M NaCI, 20 mM PIPES pH 6.8, 10 mM EDTA. 10% dextran sulfate. 5~ Denhardt's solution, 50 rnh DTT, 0.2% SDS, 100 pg/ml yeast tR'NA, and 100 fig/ ml herring sperm DNA. Prehybridization solution was removed and hybridization solution containing antisense or sense PDE 1 B 1 riboprobe added (2 x IO6 cpm/slide in 100 ~1 of prehybridization solution). Slides were hybridized for 16 hr at 42°C. After hybridization, slides were washed as described (Wilson and Higgins, 1989) being 0.2x SSC (30 mM NaCl, 3.0 mM Na, citrate, pH 7.0) at 55°C. Slides were then rinsed briefly in distilled water and air dried,for autoradiography using Hyperlilm-Bmax (Amersham). After autoradiography, slides were coated with NTB2 emulsion (Kodak; diluted 1: 1 with water) and developed as described by the manufacturer.
Immunocytochemist y. Animals were anesthetized as described above (see Animal housing and care) and perfused transcardially with PBS, followed by freshly prepared 4% paraformaldehyde dissolved in PBS pH 7.4. Brains were postfixed overnight at 4°C and sectioned (50-75 pm) in ice-cold PBS using an Oxford Vibratome. Sections remained free-floating for the immunocytochemical reaction. Immediately after cutting, sections were washed three times with TBS, pH 7.4, and endogenous peroxidase activity was inactivated by incubation in 1 mg/ ml sodium azide/TBS containing 2% H,O,. After 5 min, sections were rinsed with TBS (three washes, 10 min each) and incubated with 2% normal goat serum/0.3% Triton X-100 in TBS to reduce nonspecific binding. Primary antibody was added ( 1:250 in TBS/O. 1% T&on-X 1 OO/ 2% goat serum) for 18 hr at 4°C. Primary antibody was detected using a biotinylated secondary antibody (Vector Labs) and an avidin-horseradish peroxidase/diaminobenzidine/H,O, chromogen system. Sections were allowed to develop for 5 min and subsequently washed in TBS, mounted on gelatin-chrom alum-coated slides, and dehydrated through a series of graded alcohol/xylene steps.
Immunoprecipitution of CUM-PDE isoforms. A "PDEl A2"-specific polyclonal antiserum was prepared from a CaM-PDE antibody preparation (Kincaid, 1988 ) that contained a small amount ofcross-reactivity to the PDElBl isoform (J. W. Polli and R. L. Kincaid, unpublished observations). The cross-reactive antibody population was removed by adsorption of the antiserum to recombinant PDE 1 B 1 protein that had been immobilized on Immobilon-PF membranes. The resulting PDEl A2 antiserum did not immunoabsorb any CaM-dependent PDE activity in PC1 2 cells stably expressing the PDE 1 B 1 isozyme (Polli and Kincaid, unpublished observations) . Cytosolic tissue extracts were prepared as described above (see Isolation of brain tissues) and added to immunoprecipitation reactions (500 & final protein concentration of 0.1-0.2 mg/ml diluted in PBS) containing either the PDElBl or PDEl A2 antiserum. After gently mixing the reactants at 4°C for 90 min, 40 ~1 of Protein A-agarose (1: 1 bed vol:vol in PBS; Pierce, Rockford, IL) was added and reactions incubated for a second 90 min period. The protein A-agarose:IgG complexes were removed from the cytosolic fraction by centrifugation at 3000 x g for 10 min and CaM-dependent PDE activity assayed as described (Kincaid and Manganiello, 1988) .
Results

Immunological analyses of PDEIBI in brain
An anti-peptide antibody was raised against a region of deduced sequence located near the carboxyl terminus of the mouse brain PDE 1 B 1 (63 kDa) isoform (Polli and Kincaid, 1992) having no sequence homology to that of the PDE 1 A2 (6 1 kDa) isoform (Sonnenburg et al., 1993) . To demonstrate that the PDElBl anti-peptide antibody does not cross-react with the PDElA2 isoform, blots containing purified recombinant PDE 1 B 1 protein (generated in baculovirus-infected Sf9 insect cells) and a purified fraction of PDE 1 A2 from bovine cortex were incubated with affinity-purified PDE 1 B 1 anti-peptide antibody (Fig. 1A) . The 0.4 0.8 1.2 1.8 2 antiserum (mg protein) Figure 2 . Immunoprecipitation of CaM-PDE isoforms from wholebrain cytosol. Specific antisera for the PDE 1 B 1 and PDE 1 A2 isozymes were prepared and characterized as described in Immunoprecipitation of CaM-PDE isoforms (Materials and Methods). Whole mouse brain cytosol (100,000 x g fraction) was incubated for 90 min with varying amounts of antiserum and CaM-PDEantibody complexes were precipitated with protein A-agarose beads. CaM-dependent PDE activity in cytosol was assayed as described (Kincaid and Manganiello, 1988) . PDEl Bl antiserum (0) immunoprecipitated =3040% of the CaMdependent PDE activity, whereas the PDEl A2 antiserum (A) removed 60-70% of this activity. Control incubations using protein A-agarose alone or preimmune antiserum did not significantly alter CaM-PDE activity (data not shown). PDElBl antibody recognizes recombinant PDEl Bl (lane l), but does not react with the PDElA2 fraction (lane 2). The relative amounts of CaM-PDE isoforms in whole-brain cytosol were determined in immunoprecipitation experiments using antisera specific for the two isoforms. The PDEl B 1 antiserum was capable of immunoprecipitating = 30-40% of CaM-stimulated PDE activity from whole-brain cytosol, whereas the PDElA2 antiserum removed 60-70% ( Fig. 2 ; Polli and Kincaid, unpublished observations). PDE activity remaining in the cytosol after depletion by PDElB 1 antibody was removed by PDElA2 immunoadsorption, indicating that these two isoforms account for essentially all CaM-dependent PDE activity. Control immunoprecipitations using protein A-agarose beads alone or incubation with preimmune rabbit antisera did not cause a significant loss of CaM-PDE activity (data not shown).
To evaluate the regional expression of PDEl B 1 protein, a t blot containing cytosolic fractions from six major brain areas was incubated with the PDElBl antibody (Fig. 1B) . A single, ~63 kDa immunoreactive band was observed in all regions examined ( Fig. 1 C) ; however, the amount of immunoreactivity varied greatly between regions. Densitometric quantification of the immunoreactive bands indicated that striatum contains threeto fivefold higher PDE 1 Bl levels than cortex, olfactory bulb, and hindbrain, and 8-l 7-fold more than hippocampus and cerebellum (Fig. 10) .
Localization of PDEIBI mRNA by ISH
To compare the regional PDElB 1 protein distribution to the cellular localization of its mRNA, ISH studies were undertaken. The PDElB 1 probe used for these studies did not cross-hybridize to PDElA2 mRNA based on Southern blots prepared using portions of the PDElA2 (876 base pairs) and PDElBl (1605 base pairs) open reading frames. Even under low-stringency hybridization conditions, the %-labeled PDE 1 B 1 antisense riboprobe bound only to the PDElBl cDNA fragment, demonstrating that it is specific for the PDElBl isoform (data provided to reviewers). Autoradiograms of brain sections incubated with an %-labeled PDE 1 B 1 antisense riboprobe showed intense hybridization signal in the caudate-putamen (CP), nucleus accumbens (NA), olfactory bulb (OB), olfactory tubercle (OT), and primary olfactory cortex (Fig. 3) . Hybridization was also present in several medial thalamic nuclei (TH) such as the paraventricular nucleus (PVA), reuniens nucleus, and rhomboid nucleus. Other regions expressing PDElBl mRNA included the zona incerta (ZI), mammillary peduncle (MP), medial geniculate body (MG), nucleus of Darkshevich (Fig. 3E) , cerebral cortex, and hippocampus (H). Within the hippocampus, the dentate gyrus contained higher levels of PDEl Bl transcript than the CAl-CA4 pyramidal cell layer (Fig. 30) , over which a slight gradient of PDElBl hybridization was seen. PDEl Bl transcript was observed throughout the cell layers of the cerebral cortex especially in layers III, V, and VI (Fig. 39. A variety of brainstem nuclei such as the prepositus hypoglossal nucleus (PrH), trigeminal nerve (SP5), nucleus tractus solitarius, and raphe nucleus contain moderate amounts of PDEl B 1 mRNA (Fig. 3F) . Very little hybridization was observed in the globus pallidus (GP), substantia nigra, hypothalamus, or ventral tegmental area (Fig.  3C,E) . Control hybridizations using either a 35S-labeled PDElBl sense riboprobe (Fig. 3G) or pretreatment of sections with RNase A followed by hybridization with the 35S-labeled PDElBl antisense riboprobe (Fig. 3H) showed no significant signal.
The cellular localization of mRNA transcripts was determined by bright-and dark-field microscopy of emulsion-coated sections. Figure 4A is a dark-field photomicrograph of the hybridization of the 35S-labeled PDElBl antisense riboprobe to the caudate-putamen, nucleus accumbens, olfactory tubercle, and primary olfactory cortex. A gradient of PDE 1 B 1 expression is seen from the caudate-putamen to the nucleus accumbens. In olfactory tubercle, PDEl Bl mRNAs are abundant, while the primary olfactory cortex shows significantly lower amounts. Control hybridizations using 35S-labeled sense riboprobe (Fig.  4B) or pretreatment with RNAse A (data not shown) produced very few silver grains. At higher magnification, dark-field (Fig.  4C ) and bright-field (Fig. 40 ) microscopy of the olfactory tubercle shows that the silver grains are associated with the pyramidal layer of the olfactory tubercle and not with the islands of Calleja (IC).
The highest amount of PDElBl mRNA, by far, was found in the caudate-putamen of the basal ganglia (Fig. 5) . Silver grains were evenly distributed throughout this region and were present in both the patch and matrix compartments of striatum. In contrast, the globus pallidus and ventral pallidum showed very little hybridization (Fig. 5A,B) . Bright-field microscopy confirmed that silver grains in the caudate-putamen were localized over the cell bodies of most neurons (Fig. 5C) . A moderate amount of PDEl B 1 mRNA is present in the dentate gyrus (Fig.  6A ) and a variety of brainstem nuclei (Figs. 3F, 6B ) such as the hypoglossal nucleus, nucleus tractus solitarius, trigeminal nerve, raphe nucleus, and vestibular nucleus. Fewer silver grains were found associated with the CAI-CA4 pyramidal neurons of the hippocampus (Fig. 6A ) and the Purkinje neurons of the cerebellum (Fig. 6B) .
Immunocytochemical localization of PDEIBI in mouse brain Immunocytochemical studies showed intense PDE 1 B 1 immunoreactivity throughout the caudate-putamen, nucleus accumbens, and olfactory tubercle (Fig. 7.4) ; these regions contain the vast majority of PDElBl in brain. Immunoreactive product was also present in the dentate gyrus, substantia nigra (SN), and cerebellar Purkinje cell layer. The neuropilar immunostaining in the substantia nigra, in conjunction with the absence of PDElBl mRNA in this region (Fig. 3E) , suggests that the PDE 1 B 1 protein is localized to the striatonigral pathway. Control experiments in which the antibody was preincubated with purified PDElA2 protein had no effect on PDElB 1 immunostaining (Fig. 7A) , while preincubation of antibody with recombinant PDE 1 B 1 blocked all immunoreactivity (Fig. 7B) . In the caudate-putamen, PDE 1 B 1 immunoreactivity was ubiquitous (Fig. 8A) and was localized to the cell bodies of most medium spiny neurons. In contrast, PDElA2 immunostaining was restricted to a minor subset of cells that comprise < 10% of striatal neurons (Fig. 8B) . Based on the size of the cell body (15-30 pm) and the number of stained neurons, the PDElA2-containing Figure 6 . ISH of PDElBl mRNA in the hippocampus and brainstem. Lowmagnification (40 x) dark field of emulsion-coated sections hybridized with a 35 S-labeled antisense PDEl B 1 riboprobe shows that the majority of silver grains are found in the dentate gyrus (DC) of the hippocampus (A) and a variety of brainstem (KS) nuclei (B). Fewer silver grains are found over the CA l-CA4 hippocampal pyramidal cells or cerebellar Purkinje cells. TH, thalamus; CB, cerebellum. Scale bars, 250 Wm.
neurons are not likely to be cholinergic interneurons. It is not clear if, these cells also contain the PDE 1 B 1 isoform.
Discussion
The immunocytochemical and biochemical data presented here establish that the 63 kDa PDElBl CaM-regulated isozyme is a major neuronal form accounting for x30-40% of total CaM-PDE activity in whole mouse brain. In terms of anatomical distribution, the expression of protein and mRNA for the PDE 1 B 1 isoform in the adult is highly enriched in the caudateputamen, nucleus accumbens, and olfactory tubercle. These results agree with our initial report showing that striatum contains 4-30-fold more PDE 1 B 1 mRNA than other brain regions (Polli and Kincaid, 1992) and indicates that this biased transcript Figure 7 . Immunocytochemical localization of PDElBl in mouse brain. Sections (50 pm) were incubated with an affinity-purified PDElBl antibody that had been preabsorbed with purified PDElA2 protein from bovine cortex (1~5 molar ratio antibody:PDElA2; A) or recombinant PDElBl protein (1:5; B). The vast majority of PDElBl immunoreactivity is localized to the caudate-putamen (CP), nucleus accumbens, and olfactory tubercle (07'). Weaker immunostaining was also present in the substantia nigra (Slv), Purkinje cell layer of the cerebellum (CB), and dentate gyrus (DC). Control incubations using antibody preabsorbed with recombinant PDElBl exhibited no specific immunoreactivity (B). distribution is not due to differential rates of mRNA turnover. Perhaps equally important is the observation that the niRNA and protein of this isoform are in much lower amounts in cerebellum and the CA l-CA4 fields of the hippocampus, two areas with high immunoreactivity to a polyclonal antibody against purified CaM-PDE (Kincaid et al., 1987b) . This suggests that the robust PDE immunoreactivity in these latter two areas represents primarily that of the PDElA2 (61 kDa) isoform, a conclusion supported by Western blot data showing that the polyclonal antibody preparation reacts only weakly to baculovirus-expressed PDE 1 B 1 (Polli and Kincaid, unpublished observations) . Similarly, molecular comparison of the distribution of PDEl Bl with the PDElA2 CaM-PDE isoform reveals striking differences. PDE lA2 mRNA detected on Northern blots is evenly distributed in cerebral cortex, basal ganglia, hippocampus, and cerebellum (Sonnenburg et al., 1993) . Consistent with these data, PDElA2 immunoreactivity is present in these regions and the intensity of staining on immunoblots is similar among cortex, hippocampus, and striatum (Polli and Kincaid, unpublished observations) . From immunoblots and immunoprecipitation experiments, we estimate that the PDElBl protein is higher than PDElA2 (three to fivefold) in striatum and lower (fourto sixfold) in cerebellum. Although there appears to be significant disparity in the expression of these CaM-PDE isoenzymes within these two regions, large differences in the amounts of PDE 1 B 1 and PDEl A2 immunoreactivity are not seen in other brain areas.
The most striking relationship seen in this study is the remarkable coincidence of our PDE 1 B 1 ISH results with the expression of D, dopamine receptor mRNA, which is also highest in caudate-putamen, nucleus accumbens, and olfactory tubercle (Weiner et al., 199 1) . Activation of D, receptors stimulates adenylyl cyclase activity through the G-protein G, (Creese et al., 1983) , resulting in the synthesis of CAMP. This anatomical colocalization is consistent with a purposeful linkage of these signaling components. Although there is strong evidence suggesting that D, and Dz receptors are colocalized in most striatal neurons (Surmeier et al., 1992) , it seems unlikely that coexpression of D, receptor and PDE 1 B 1 would be related necessarily since D, receptor activation inhibits adenylyl cyclase. The dopamine D, receptor mRNA is enriched in the islands of Calleja of the olfactory tubercle (Sokoloff et al., 1990) , a region devoid of PDElBl mRNA (Fig. 4C,D) and protein (Fig. 7A) , suggesting that PDElBl does not play an important role in modulating the D, signal. Indeed, we have recently obtained evidence suggesting that the major CaM-regulated PDE in the islands of Calleja is the PDE 1 A2 isoform (Polli and Kincaid, unpublished observations) .
Even though the majority of PDElBl mRNA and protein is localized to regions that receive high amounts of dopaminergic innervation, PDElBl is expressed in other brain areas having less extensive dopaminergic innervation. For example, the mammillary body, medial geniculate body, zona incerta, paraventricular thalamic nucleus, and several brainstem nuclei express moderate levels of PDElBl mRNA. In these areas, a variety of other neurotransmitter receptors can modulate cyclic nucleotide levels. Muscarinic receptors m2 and m4 are negatively coupled to adenylyl cyclase, while activation of m 1, m3, and m5 receptors can, under specific conditions, increase cellular CAMP levels (Richards, 199 1; Baumgold, 1992) . Similarly, glutamate and NMDA have been demonstrated to increase cyclic nucleotide concentrations (Shimizu et al., 1974 (Shimizu et al., , 1975 Schmidt et al., 1976 Schmidt et al., , 1977 , as well as inhibiting adenylyl cyclase activity (Itano et al., 1992; Tanabe et al., 1992) . Because of the diversity and complexity of neurotransmitter receptor families, it may be difficult to establish a clear anatomical or biological connection between these receptors and the expression of PDE 1 B 1. Rather, it may be more appropriate to consider the need for Ca2+-dependent regulation of cyclic nucleotide levels in these regions.
The immunocytochemical staining of PDEl B 1 within the striatum is similar to that seen for calcineurin (PP-2B), the CaMdependent protein phosphatase Wood et al., 1980; Goto and Hirano, 1989; Polli et al., 199 l) , suggesting. that these CaM-binding proteins are colocalized in striatal neurons. Therefore, it seems plausible that one physiological function of PDE 1 B 1 in striatum might be to participate along with calcineurin in a concerted Ca*+/CaM-regulated antagonism of the CAMP second messenger system. Studies have shown that dopamine or CAMP analogs increase the phosphorylation of the Figure 8 . Immunocytochemical localization of PDElB 1 in caudate-putamen. Sections were stained with an affinity-purified PDEl Bl antibody that was preabsorbed with purified PDE 1 A2 protein from bovine cortex ( 1:5 molar ratio antibody:PDE 1 A2; A) and PDE 1 A2 antibody preincubated with recombinant PDE 1 B 1 protein (1: 5; B). Intense PDE 1 B 1 immunoreactivity is found in the cell bodies of the majority of medium spiny neurons, whereas PDElA2 immunoreactivity is restricted to a small subset of striatal neurons. Magnification, 100x; scale bars, 100 pm. phosphatase inhibitor DARPP-32 (dopamineand CAMP-regulated phosphoprotein), resulting in the inhibition of the broad specificity protein phosphatase (PP)-1 (Hemmings et al., 1984; Shenolikar and Naim, 199 1) . The phosphorylated form of DARPP-32 is a preferred substrate for calcineurin (King et al., 1984) and its dephosphorylation reverses the CAMP-induced suppression of PP-1. An increase in Ca2+ following receptor activation would activate both PDE 1 B 1 and calcineurin, leading to the hydrolysis of cyclic nucleotides, the dephosphorylation of DARPP-32, and the activation of PP-1. Such a mechanism would serve to downregulate CAMP signaling cascades rapidly and may be particularly important as a means of preventing desensitization of dopaminergic response pathways, both at the cellular and at the systems levels. Unique patterns of linkage between Ca2+-and cyclic nucleotide-mediated signaling pathways are suggested by a careful examination of cyclic nucleotide biosynthetic components in brain. Notably, the distribution of the CaM-sensitive adenylyl cyclase in rat brain appears to be very different than that for PDElBl CaM-dependent PDE. Expression of mRNA for the CaM-sensitive adenylyl cyclase is highest in cerebellum and dentate gyrus (Xia et al., 199 l) , structures with low to moderate levels of PDEl B 1 mRNA. Regions abundant in PDEl B 1 mRNA, such as caudate-putamen, nucleus accumbens, and brainstem, have no detectable CaM-sensitive adenylyl cyclase signal. The mutually exclusive distribution ofthese CaM-sensitive signaling components in some structures may suggest that the Ca*+ signal in PDE 1 B 1 -containing neurons plays an obligatory role in counteracting CAMP generation, rather than augmenting cyclic nucleotide accumulation. On the other hand, the distribution of a soluble guanylyl cyclase in rat brain is similar to that of PDE 1 B 1. Expression of this guanylyl cyclase mRNA is prominent in cortex, caudate-putamen, nucleus accumbens, and olfactory tubercle, while moderate levels of mRNA are found in the hippocampus, cerebellum, and brainstem (Matsuoka et al., 1992) . The soluble guanylyl cyclase form is responsible for neurotransmitter-induced cGMP elevations in neurons. Recently a new CaM-insensitive adenylyl cyclase was shown to be selectively expressed in the striatum and was suggested to be responsible for the synaptic actions of dopamine (Glatt and Snyder, 1993) . Since guanylyl cyclase and CaM-insensitive adenylyl cyclase activities are highest in striatum (Matsuoka et al., 1992) , it maybe necessary to have large amounts of CaM-regulated PDE to achieve a vigorous reversal of cyclic nucleotide accumulation in response to elevated cellular Ca*+. Furthermore, unlike the PDElA2 isoform, PDElBl activity is not subject to potential inhibition via phosphorylation by CAMP-dependent protein kinase Wang, 1985, 1986; Hashimoto et al., 1989 ), a modification that would delay the removal of cyclic nucleotides, resulting a prolonged CAMP response. This supports the idea that in striatal neurons PDElBl is essential to ensure an immediate Ca*+-regulated antagonism of the CAMP signal. By contrast, the apparent colocalization of PDE 1 A2 and CaM-sensitive adenylyl cyclases in some neurons (e.g., hippocampal
pyramidal cells) may suggest a means to temporarily sustain cyclic nucleotide action in response to Ca2+, through increased synthesis and reduced degradative activity. Such an alternative strategy might be needed for proper temporal integration of excitatory input or to provide for long-term potentiation (Frey et al., 1993) . Thus, despite their otherwise similar enzymological properties (i.e., V,,,, substrate affinities), the two major neural CaM-PDE isozymes may have operationally distinct roles. Future studies on the cellular localization of other CaM-PDE isozymes and the effect of phosphotylation in vivo on enzyme activity will be needed to establish the biological roles of the PDEl Bl and PDElA2
CaM-dependent isoforms in neuronal signaling.
